Measures for control of influenza

Area of Science:

• Virology
• Epidemiology
• Vaccinology
• Pharmacology

Background:

• Influenza viruses cause recurrent global illnesses and epidemics.
• Inactivated influenza vaccines are a primary control measure, particularly for high-risk groups.
• Existing antiviral treatments like amantadine have limitations such as resistance and side effects.

Purpose of the Study:

• To review current and emerging strategies for influenza prevention and treatment.
• To highlight the expanding options beyond traditional inactivated vaccines.
• To discuss the potential impact of new antivirals and vaccines on public health.

Main Methods:

• Review of existing literature on influenza vaccines and antiviral agents.
• Analysis of the efficacy and limitations of current and novel influenza control measures.
• Discussion of emerging influenza prevention and treatment modalities.

Main Results:

• Live attenuated cold-adapted influenza vaccines (nasal spray) show promise, especially for children and young adults.
• New neuraminidase inhibitors (zanamivir, GS4104) are effective for influenza A and B prevention and treatment with varying side effect profiles.
• Antiviral agents like ribavirin also demonstrate efficacy in influenza treatment.

Conclusions:

• A range of new influenza vaccines and antiviral therapies are becoming available.
• Optimal utilization of these diverse measures can enhance individual and population-level control of influenza.
• These advancements hold the potential to significantly reduce the impact of seasonal influenza and prevent community-wide epidemics.